Top Markets
#1 Black Phoenix Black Phoenix +736.57%
#2 Islamic Coin Islamic Coin +146.17%
#3 THORChain THORChain +26.71%
#4 MiL.k Alliance MiL.k Alliance +26.65%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.17%
#6 THORChain Yield THORChain Yield +20.24%
#7 Bless Bless +19.93%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +14.36%
#9 TENDIES TENDIES +14.32%
#10 Tutorial Tutorial +12.78%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rank in Stocks #5454
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Share Price
$93.80
Last synced: 2025-04-28
Market Cap
$2.68B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Aerovate Therapeutics, Inc. (AVTE)

Category

Healthcare
P/B ratio for Aerovate Therapeutics, Inc. (AVTE)
P/B ratio as of August 2026 TTM: 0.37
According to Aerovate Therapeutics, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0.37. At the end of 2023 the company had a P/B ratio of 5.44.
P/B ratio history for Aerovate Therapeutics, Inc. from 2020 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 0.37 -100.02%
2024 -1.62K -29,830.16%
2023 5.44 -3.77%
2022 5.66 238.93%
2021 1.67 -99.12%
2020 189.49 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 1,605.27%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 1,578.22%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 897.23%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 573.68%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH